Company news: Rua Bioscience; IDT Australia; Emyria; Elixinol Wellness; Neurotech; Hygrovest; Releaf Group/ICCM; Botanix by Martin Lane August 30, 2023April 30, 2024 NZX-listed Rua Bioscience’s losses before tax narrowed to NZ$5.96 million in FY23, compared to $7.49m in […]
Company news: MedReleaf; Vitura Health; MGC Pharma; Rua Bioscience by Martin Lane April 13, 2023April 30, 2024
Rua Bioscience vows to continue product supply despite taking axe to local manufacturing by Steve Jones March 27, 2023April 30, 2024
Company news: Bod; Incannex; Medlab; Rua Bioscience; Emyria by Martin Lane October 20, 2022April 29, 2024
Company news: Cann Group; Cronos; Releaf Group; Rua Bioscience; Incannex by Martin Lane October 12, 2022April 29, 2024
Financial results: Avecho; AusCann; Zelira; Elixinol; Cann Group; Incannex; Creso Pharma; Medlab; Rua Bioscience by Steve Jones and Martin Lane September 1, 2022April 29, 2024
Ecofibre; LGP; Creso Pharma; Rua Bioscience; The Pain Clinic; MGC Pharma by Martin Lane July 28, 2022April 29, 2024
Company news: Creso Pharma; Wellnex Life; Zyus Life Sciences; Emyria; MGC Pharma; Rua Bioscience by Martin Lane July 21, 2022April 29, 2024
